These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 20799097)

  • 1. Emergence of vancomycin-intermediate Staphylococcus aureus from predominant methicillin-resistant S. aureus clones in a Korean hospital.
    Cha HY; Kim HO; Jin JS; Lee JC
    J Microbiol; 2010 Aug; 48(4):533-5. PubMed ID: 20799097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emergence of vancomycin-intermediate and -resistant Staphylococcus aureus among methicillin-resistant S. aureus isolated from clinical specimens in the northwest of Iran.
    Ghahremani M; Jazani NH; Sharifi Y
    J Glob Antimicrob Resist; 2018 Sep; 14():4-9. PubMed ID: 29454049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High prevalence of a globally disseminated hypervirulent clone, Staphylococcus aureus CC121, with reduced vancomycin susceptibility in community settings in China.
    Shen P; Zhou K; Wang Y; Song J; Liu Y; Zhou Y; Xiao Y
    J Antimicrob Chemother; 2019 Sep; 74(9):2537-2543. PubMed ID: 31203362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and Microbiological Characteristics of Heteroresistant and Vancomycin-Intermediate Staphylococcus aureus from Bloodstream Infections in a Brazilian Teaching Hospital.
    da Costa TM; Morgado PG; Cavalcante FS; Damasco AP; Nouér SA; Dos Santos KR
    PLoS One; 2016; 11(8):e0160506. PubMed ID: 27575698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacodynamic activity of ceftobiprole compared with vancomycin versus methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-intermediate Staphylococcus aureus (VISA) and vancomycin-resistant Staphylococcus aureus (VRSA) using an in vitro model.
    Zhanel GG; Voth D; Nichol K; Karlowsky JA; Noreddin AM; Hoban DJ
    J Antimicrob Chemother; 2009 Aug; 64(2):364-9. PubMed ID: 19454524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of vancomycin-intermediate Staphylococcus aureus (VISA) and heterogeneous VISA among methicillin-resistant S. aureus with high vancomycin minimal inhibitory concentrations in Taiwan: A multicenter surveillance study, 2012-2013.
    Huang SH; Chen YC; Chuang YC; Chiu SK; Fung CP; Lu PL; Wang LS; Wu TL; Wang JT
    J Microbiol Immunol Infect; 2016 Oct; 49(5):701-707. PubMed ID: 26320398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clonal dissemination of meticillin-resistant and vancomycin-intermediate Staphylococcus aureus in a Taiwanese hospital.
    Hsueh PR; Lee SY; Perng CL; Chang TY; Lu JJ
    Int J Antimicrob Agents; 2010 Oct; 36(4):307-12. PubMed ID: 20685086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Community-Onset Methicillin-Resistant
    Bae E; Kim CK; Jang JH; Sung H; Choi Y; Kim MN
    Ann Lab Med; 2019 Mar; 39(2):158-166. PubMed ID: 30430778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emergence of methicillin-resistant, vancomycin-intermediate Staphylococcus aureus among patients associated with group A Streptococcal pharyngitis infection in southern India.
    Gowrishankar S; Thenmozhi R; Balaji K; Pandian SK
    Infect Genet Evol; 2013 Mar; 14():383-9. PubMed ID: 23337611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Characterization of Methicillin and Vancomycin Resistant
    Jahanshahi A; Zeighami H; Haghi F
    Microb Drug Resist; 2018 Dec; 24(10):1529-1536. PubMed ID: 29883257
    [No Abstract]   [Full Text] [Related]  

  • 11. First report of a sequence type 239 vancomycin-intermediate Staphylococcus aureus isolate in Mainland China.
    Zhang X; Hu Q; Yuan W; Shang W; Cheng H; Yuan J; Zhu J; Hu Z; Li S; Chen W; Hu X; Rao X
    Diagn Microbiol Infect Dis; 2013 Sep; 77(1):64-8. PubMed ID: 23876353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accessory gene regulator (agr) dysfunction in Staphylococcus aureus bloodstream isolates from South Korean patients.
    Chong YP; Kim ES; Park SJ; Park KH; Kim T; Kim MN; Kim SH; Lee SO; Choi SH; Woo JH; Jeong JY; Kim YS
    Antimicrob Agents Chemother; 2013 Mar; 57(3):1509-12. PubMed ID: 23254438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of oritavancin against community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA), vancomycin-intermediate S. aureus (VISA), vancomycin-resistant S. aureus (VRSA) and daptomycin-non-susceptible S. aureus (DNSSA).
    Saravolatz LD; Pawlak J; Johnson LB
    Int J Antimicrob Agents; 2010 Jul; 36(1):69-72. PubMed ID: 20413274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clonal clusters and virulence factors of methicillin-resistant
    Abimannan N; Sumathi G; Krishnarajasekhar OR; Sinha B; Krishnan P
    Indian J Med Microbiol; 2019; 37(3):326-336. PubMed ID: 32003329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibiotic susceptibility and genomic variations in Staphylococcus aureus associated with Skin and Soft Tissue Infection (SSTI) disease groups.
    Changchien CH; Chen SW; Chen YY; Chu C
    BMC Infect Dis; 2016 Jun; 16():276. PubMed ID: 27287530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The evolution of Staphylococcus aureus.
    Deurenberg RH; Stobberingh EE
    Infect Genet Evol; 2008 Dec; 8(6):747-63. PubMed ID: 18718557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative genomics of vancomycin-resistant Staphylococcus aureus strains and their positions within the clade most commonly associated with Methicillin-resistant S. aureus hospital-acquired infection in the United States.
    Kos VN; Desjardins CA; Griggs A; Cerqueira G; Van Tonder A; Holden MT; Godfrey P; Palmer KL; Bodi K; Mongodin EF; Wortman J; Feldgarden M; Lawley T; Gill SR; Haas BJ; Birren B; Gilmore MS
    mBio; 2012; 3(3):. PubMed ID: 22617140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial susceptibility of Staphylococcus aureus and characterization of methicillin-resistant Staphylococcus aureus isolated from bovine mastitis in Korea.
    Nam HM; Lee AL; Jung SC; Kim MN; Jang GC; Wee SH; Lim SK
    Foodborne Pathog Dis; 2011 Feb; 8(2):231-8. PubMed ID: 21034263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular characterization and susceptibility of methicillin-resistant and methicillin-susceptible Staphylococcus aureus isolates from hospitals and the community in Vladivostok, Russia.
    Baranovich T; Zaraket H; Shabana II; Nevzorova V; Turcutyuicov V; Suzuki H
    Clin Microbiol Infect; 2010 Jun; 16(6):575-82. PubMed ID: 19681959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of selected gene mutations to resistance in clinical isolates of vancomycin-intermediate Staphylococcus aureus.
    Hafer C; Lin Y; Kornblum J; Lowy FD; Uhlemann AC
    Antimicrob Agents Chemother; 2012 Nov; 56(11):5845-51. PubMed ID: 22948864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.